Biotechnology’s strong track record can be traced directly to the men and women working in the field. For them, biotechnology is not just an occupation; it is a mission and a calling to solve the greatest challenges of our time: to unlock the essence of life itself and to use that knowledge in the service of compassion and in the name of hope.
They are entrepreneurial. They are risk takers. They are driven by science and are stubborn in their refusal to accept the status quo. Their passion and perseverance is why nearly 70% of the industry’s clinical pipeline is attributed to small companies. These companies are on the cutting edge of the next generation of innovation, including major advances in gene therapy, immunotherapy and RNAi therapy. These innovations are poised to transform medicine in the 21st Century.